z-logo
open-access-imgOpen Access
Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature
Author(s) -
Christopher Iriarte,
Jonathan H. Young,
Michael S. Rabin,
Nicole R. LeBoeuf
Publication year - 2022
Publication title -
jto clinical and research reports
Language(s) - English
Resource type - Journals
ISSN - 2666-3643
DOI - 10.1016/j.jtocrr.2022.100415
Subject(s) - dapsone , medicine , osimertinib , dermatology , lung cancer , vasculitis , malignancy , systemic vasculitis , skin biopsy , discontinuation , cancer , biopsy , surgery , adenocarcinoma , pathology , disease , ros1

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here